Vitelliform Macular Dystrophy, also known as juvenile-onset vitelliform macular dystrophy, is related to macular dystrophy, vitelliform, 2 and macular dystrophy, vitelliform, 3. An important gene associated with Vitelliform Macular Dystrophy is BEST1 (Bestrophin 1), and among its related pathways/superpathways are Transport of inorganic cations/anions and amino acids/oligopeptides and Ion channel transport. The drugs Ranibizumab and Sodium citrate have been mentioned in the context of this disorder. Affiliated tissues include retina and eye, and related phenotypes are nervous system and pigmentation